Sugimoto, Yuka http://orcid.org/0000-0002-3263-3270
Nagaharu, Keiki
Ohishi, Kohshi
Nakamura, Maki
Ikejiri, Makoto
Nakatani, Kaname
Mizutani, Minoru
Tamaki, Shigehisa
Ikeda, Takeshi
Tawara, Isao
Katayama, Naoyuki
Article History
Received: 28 December 2020
Revised: 10 March 2021
Accepted: 11 March 2021
First Online: 26 March 2021
Declarations
:
: Y. Sugimoto has received honoraria from Novartis and is an accepted researcher from Shojunkai Takeuchi Hospital. Y. Sugimoto and I. Tawara received funding from Takara Bio. Y. Sugimoto, K. Nagaharu, K. Ohishi, I. Tawara, and N. Katayama have received research support from Astellas, Kyowa Kirin, and Ono. K. Ohishi has received funding from PharmaEssentia. N. Katayama has received honoraria from Novartis, Celgene, and Chugai. No other authors have any conflicts of interest to declare.